Search Results

HS-173 25mg 25mg  | Purity Not Available

Adooq Bioscience

HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.

More Information Supplier Page

HS-173 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.

More Information Supplier Page

HS-173 10mg 10mg  | Purity Not Available

Adooq Bioscience

HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.

More Information Supplier Page

TTNPB 50mg 50mg  | Purity Not Available

Adooq Bioscience

TTNPB enhances reprogramming efficiency in chemically induced pluripotent stem cells (CiPSCs).

More Information Supplier Page

TTNPB 25mg 25mg  | Purity Not Available

Adooq Bioscience

TTNPB enhances reprogramming efficiency in chemically induced pluripotent stem cells (CiPSCs).

More Information Supplier Page

TTNPB 10mg 10mg  | Purity Not Available

Adooq Bioscience

TTNPB enhances reprogramming efficiency in chemically induced pluripotent stem cells (CiPSCs).

More Information Supplier Page

INCB024360 analog 50mg 50mg  | Purity Not Available

Adooq Bioscience

INCB024360 is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities.

More Information Supplier Page

HS-173 50mg 50mg  | Purity Not Available

Adooq Bioscience

HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.

More Information Supplier Page

CO-1686 10mg 10mg  | Purity Not Available

Adooq Bioscience

CO-1686 is a novel, oral, targeted covalent (irreversible) inhibitor of the cancer-causing mutant forms of epidermal growth factor receptor (EGFR) currently being studied for the treatment of non-small cell lung cancer (NSCLC).

More Information Supplier Page